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Abstract We have identified and characterised a cDNA
encoding a novel gene, designated myocyte stress 1 (ms1), that
is up-regulated within 1 h in the left ventricle following the
application of pressure overload by aortic banding in the rat. The
deduced ms1 protein of 317 amino acids contains several putative
functional motifs, including a region that is evolutionarily
conserved. Distribution analysis indicates that rat ms1 mRNA
expression is predominantly expressed in striated muscle and
progressively increases in the left ventricle from embryo to
adulthood. These findings suggest that ms1 may be important in
striated muscle biology and the development of pressure-induced
left ventricular hypertrophy. % 2002 Published by Elsevier Sci-
ence B.V. on behalf of the Federation of European Biochemical
Societies.
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1. Introduction
Left ventricular hypertrophy (LVH) is an adaptation of the
heart to chronic pressure/volume overload. Although immedi-
ately bene¢cial in reducing wall stress, in the long term LVH
is an important independent risk factor for cardiovascular
morbidity and mortality [1]. The cellular hallmark of LVH
is hypertrophic growth of the cardiac myocyte. Several genes
involved in the pathogenesis of LVH have already been iden-
ti¢ed, and a characteristic pattern of gene expression has
emerged [2]. Shortly after a pressure stimulus, there is an
induction of transcription factor-coding early genes in the
left ventricle such as the proto-oncogenes c-myc, c-jun and
c-fos [3]. This is followed by the re-expression of genes that
are only otherwise expressed in the left ventricle during foetal
development, such as atrial and brain natriuretic peptides [4]
and shifts to foetal L-myosin heavy chain and skeletal K-actin
isoforms [5]. An increase in protein content and a re-organ-
isation of contractile elements from a series to a parallel ar-
rangement results in the hypertrophic phenotype.
The molecular mechanisms that govern LVH are unclear. A
number of signalling pathways involving downstream mole-
cules such as GKq, protein kinase C (PKC), small GTPases,
members of the mitogen-activated protein kinase family, cal-
cineurin, and transcription factors such as AP-1, NFAT-3,
GATA-4, MEF-2C and NF-UB have all been implicated [6].
However, none of these molecules has been shown to be both
necessary and su⁄cient for hypertrophic growth. Progress in
identifying other key regulatory molecules has been hindered,
partly due to the candidate gene approach that has been em-
ployed. Recent advances in molecular techniques have led to
the evolution of expression pro¢ling methods such as di¡er-
ential display [7], serial analysis of gene expression [8], molec-
ular indexing [9] and cDNA array screening [10], enabling a
more comprehensive assessment of gene expression in disease
states. We have developed an e⁄cient method of expression
pro¢ling using the principle of molecular indexing [11]. In the
present study, we have applied molecular indexing to study
the early stages of pressure-induced LVH in a rat model of
aortic banding, in order to identify novel regulatory molecules
involved in the initial signalling that leads to the develop-
ment of LVH. The isolation and characterisation of a novel
gene, myocyte stress 1 (ms1; GenBank accession number
AF336113), that is markedly up-regulated within 1 h of a
pressure stimulus, is described.
2. Materials and methods
2.1. Animals and model
A rat model of pressure overload-induced LVH was generated by
supra-renal abdominal aortic banding of 10-week-old male Wistar-
Kyoto (WKY) rats, as described previously [12]. Age- and weight-
matched banded and sham-operated animals were killed at 30 min,
1 h, 4 h, 1 day, 4 days, 7 days and 28 days post-operation (n=10 per
group per time point). Total RNA was prepared from the left ven-
tricles of animals using Trizol (Life Technologies). The development
of LVH was assessed by comparing LV mass indices (LV weight/body
weight) between groups, and the induction of mRNA expression of
the hypertrophic marker atrial natriuretic peptide by Northern blot-
ting [12].
2.2. Molecular indexing
This was performed as described previously [11]. Brie£y, double-
stranded cDNA produced in parallel from 27 Wg of pooled (n=10
animals per group) total LV RNA from 4 h sham and banded groups,
was digested with the class IIS enzyme BbvI before ligation to pools of
tagged adapters with sequence-speci¢c four-base overhangs of all pos-
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sible sequences. Polymerase chain reaction (PCR) ampli¢cation of
each adaptered cDNA pool was performed for side-by-side analysis
of sham and banded products on a 4.8% polyacrylamide gel and
autoradiography. Putative di¡erentially expressed bands were cloned
into the TA vector, pGEM-T (Promega), and Northern blotting anal-
ysis [11] of pooled 4 h RNA from sham and banded animals was
carried out to con¢rm di¡erential expression. The sequences of cloned
di¡erentially expressed fragments were determined by FS dye termi-
nator chemistry (Perkin Elmer), using M13 forward and reverse prim-
ers.
2.3. ms1 mRNA analysis
2.3.1. ms1 mRNA expression in left ventricles of individual animals
4 h post-banding. The expression of ms1 in individual sham and
banded animals (n=5 per group) was assessed by semi-quantitative
reverse transcription-PCR (RT-PCR). Fifty nanograms of cDNA
(equivalent from the appropriate RT reaction) were PCR-ampli¢ed
using forward (5P-ACATTCCCTCTTTAGCCAGTGC-3P) and re-
verse (5P-TAACATTCCAGAGCAGTTTGCC-3P) primers, of the
ms1 full-length cDNA sequence. The thermocycling parameters were
1 cycle of 94‡C, 1 min 30 s; 25 cycles of 94‡C, 30 s; 60‡C, 30 s; 72‡C,
1 min 30 s; a ¢nal extension step was performed at 72‡C for 10 min.
The housekeeping gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was used as a loading control, and PCR-ampli¢ed for 21
cycles under the same thermocycling conditions as for ms1, using
forward (5P-GCCAGCCTCGTCTCATAGACAA-3P) and reverse
(5P-GGGATGGAATTGTGAGGGAGAT-3P) primers. Relative ms1
expression between groups was assessed by spot densitometry (Al-
phaimager 2000, Alphaimager Corp.) of bands and corrected for
GAPDH.
2.3.2. Temporal expression of ms1 mRNA in left ventricle after
banding. Northern blotting was carried out essentially as described
previously [12]. A random-prime (Life Technologies) 32P-labelled ms1
indexing-derived cDNA fragment (467 bp) was used as probe and a
terminal deoxynucleotide transferase (Amersham-Pharmacia) end-la-
belled oligonucleotide for GAPDH was used as a loading control.
2.3.3. Tissue distribution. Total RNA was prepared from heart,
liver, brain, kidney, testis, adrenals and intercostal muscle from adult
WKY rats and also from the A10 rat vascular smooth muscle cell line,
using Trizol, and analysed by RT-PCR.
2.3.4. Ontogeny analysis. Total RNA was prepared from the left
ventricles of 18-day-old embryos, 2-day-old neonates and 12-week-old
adult Wistar rats and analysed using RT-PCR, as described above.
2.4. Full-length sequence of ms1
Rapid ampli¢cation of cDNA ends (RACE) was performed from
pooled total RNA from the 4 h banded group, using 5P and 3P RACE
kits (Life Technologies). The kit adapter-primers (AP) used were as
follows: AP1, 5P-TAGCACGACTCAGAGCTCAT-3P, AP2, 5P-TAG-
CACGACTCAGAGCTCATTTTTTTTTTTTTTTTTT-3P, AP3, 5P-
TAGCACGACTCAGAGCTCATGGGGIIGGGIIGGGIIG-3P. The
following ms1-speci¢c primers (designated by the orientation of the
cloned ms1 indexing-derived fragment) were used: ms1 sense 1, 5P-
CTCAGTCACGACTCGCCAACGC-3P ; 2, 5P-ATGGAACAGGAG-
GAGCCCAAGT-3P ; 3, 5P-GGAACAGGAGGAGCCCAAGTGG-
3P ; ms1 antisense 1, 5P-AGACCTCCGTGGCTTCCTCAGA-3P ; 2,
5P-CTCCGTGGCTTCCTCAGAGCCT-3P ; 3, 5P-TGGCTTTGGA-
GACGGAGGTT-3P. Brie£y, for 3P RACE, reverse transcription
was performed using primer AP2 before carrying out nested PCR
ampli¢cations with primer AP1 in combination with ms1 sense or
antisense primers 2 and then 3. In 5P RACE, the reverse transcription
was carried out using ms1 sense or antisense primer 1, before tailing
the cDNA and performing nested PCR ampli¢cations using primers
AP3 and AP1 in combination with ms1 sense or antisense primers 2
and 3, respectively. The sense and antisense 5P and 3P RACE products
were gel-puri¢ed and cloned into pGEM-T before sequencing ¢ve
independent clones of each.
2.5. Chromosomal localisation and gene structure of ms1
A subset of 96 hybrids (10 ng DNA each) of the T55 radiation
hybrid (RH) rat panel (Research Genetics) was screened by touch-
down PCR with 67^61‡C annealing temperature, using forward (5P-
GGCCGATGAACACATACAGTCA-3P) and reverse (5P-TAA-
CATTCCAGAGCAGTTTGCC-3P) primers located at positions
791^892 and 1267^1246, respectively, of the ms1 cDNA sequence.
Samples were electrophoresed on a 3% agarose gel and the data an-
alysed using the MultiMap program [13], before two-point analysis
was used to ¢nd the nearest RH framework marker. The approximate
positions of intron^exon boundaries of the genomic sequence were
located by PCR walking using combinations of forward (5P-
ACATTCCCTCTTTAGCCAGTGC-3P, 5P-AGGTGGCTGCTGCC-
AGGATTAA-3P, 5P-TTGCACTCCCAGGCAAACAGAT-3P and 5P-
GGCCGATGAACACATACAGTCA-3P) and reverse (5P-TAACA-
TTCCAGAGCAGTTTGCC-3P, 5P-TCCACTTGGCTGTATTTCC-
GAT-3P and 5P-ATGCTCGTACCTGTGGCTCAGG-3P) and primers
spanning di¡erent regions along the length of the ms1 cDNA se-
quence and comparing product sizes from RNA and genomic DNA
templates. The precise boundaries were then determined by direct
sequencing of a PCR product.
2.6. Bioinformatic analysis of rat ms1
A nucleotide database similarity search was performed using the
BLAST algorithm [14]. A database search to ¢nd functional motifs
in untranslated regions (UTRs) was carried out using the UTRScan
tool (http://www.bigarea.area.ba.cnr.it :8000/EmbIT/UTRHome/).
The ms1 mRNA was translated in all six reading frames by the
open reading frame (ORF) ¢nder tool at (http://www.ncbi.nlm.
nih.gov/gorf/gorf.html) to deduce the putative protein sequence,
which was analysed using the integrated PIX program at (http://
www.hgmp.mrc.ac.uk).
3. Results
3.1. Molecular indexing
We embarked on a molecular indexing approach [11] to
identify genes that are regulated shortly after the imposition
of pressure overload on the rat LV. Out of 3181 bands de-
tected in the scan, 124 were identi¢ed as potentially di¡eren-
Fig. 1. A: Representative Northern blot of pooled (n=6^10 per
group at each time point) LV total RNA showing the time course
of ms1 mRNA expression following aortic banding. SH= sham,
BA=banded. B: Densitometric analysis of ms1 mRNA expression
in 4 h individual animals (n=5 per group). Bar graph shows mean
ms1/GAPDH optical density ratios of RT-PCR products from left
ventricles of sham and banded animals at 4 h post-operation.
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tially expressed. So far di¡erential expression has been con-
¢rmed for seven fragments, which include known genes and
also a 467-bp fragment with database sequence similarity to
expressed sequence tags (ESTs) but not to any known genes.
The present report characterises this novel gene that we have
named myocyte stress 1 (ms1).
3.2. Up-regulation of ms1 mRNA expression in the left
ventricle after aortic banding
The time course of ms1 mRNA expression in the left ven-
tricle after aortic banding is shown in Fig. 1A. The ¢ndings
indicate a pronounced early up-regulation (within 1 h), with a
peak expression before 1 day, well before any detectable in-
crease in LV mass (Fig. 1A). Semi-quantitative RT-PCR anal-
ysis con¢rmed the over-expression of ms1 at 4 h after banding
in the left ventricles of individual animals (Fig. 1B). Mean
optical density ratios of ms1/GAPDH mRNAs are
0.31S 0.105 and 0.94S 0.284 for sham and banded groups,
respectively, indicating an about three-fold increase in ms1
mRNA expression after banding (P=0.002).
3.3. Tissue distribution and ontogeny of ms1 mRNA expression
in myocardium
ms1 mRNA is expressed at high levels in adult rat heart and
skeletal muscle, but at very low levels in the adrenals, brain,
kidney, liver and testis (Fig. 2A). Fig. 2B shows that ms1
mRNA is expressed in the rat left ventricle during embryo-
genesis and is post-natally up-regulated through to adulthood.
3.4. Sequence, chromosome localisation and gene structure of
ms1
RACE of the ms1 cloned indexing fragment revealed the 5P
and 3P £anking regions to be 193 bp and 627 bp in length,
respectively, indicating that the full-length transcript size for
this gene is 1287 bases. The nucleotide sequence is shown in
Fig. 3A. Screening of RH panels mapped rat ms1 to chromo-
some 7 near the microsatellite marker D7Got54 (467cR), with
a lod score of 10.9. PCR walking showed that ms1 has a
relatively simple genomic organisation of two exons (703 bp
and 584 bp) that are located 5P and 3P, respectively, of an
intron of approximately 2.7 kb.
3.5. Bioinformatic analysis of msl cDNA
The largest open reading frame (954 nucleotides) predicts a
317-amino acid protein of approximately 36 kDa (Fig. 3A).
The critical nucleotides surrounding the start codon are iden-
tical (at the +4 and 33 positions) to the Kozak consensus (A/
GCCAUGG) ribosome binding sequence [15], suggesting that
this is the likely site for translation initiation. This deduction
is supported by the immunoprecipitation of an appropriately
sized protein produced from in vitro transcribed^translated
ms1, by an anti-ms1 antiserum raised to a C-terminal region
of this ORF (data not shown). The deduced ms1 protein se-
quence contains several putative functional domains including
two overlapping nuclear localisation sites and protein phos-
phorylation motifs (e.g. PKA, PKC, casein kinase and tyro-
sine kinase). In addition, a putative internal ribosome entry
site (IRES) is present in the 3P UTR (Fig. 3A).
BLAST searches revealed that ms1 full-length cDNA and
putative protein show no signi¢cant homology to any known
genes at date of submission. However, there is signi¢cant
identity of speci¢c regions of ms1 mRNA with cDNA and
Fig. 2. A: RT-PCR analysis showing the distribution of ms1
mRNA in rat tissues. AD=adrenal gland, BR=brain, HT=whole
heart, KD=kidney, LI= liver, SK= skeletal muscle, LV= left ven-
tricle, TS= testis. B: RT-PCR analysis showing the developmental
expression of rat ms1 mRNA in the LV. E18= embryonic day 18,
N2d=2-day-old neonate and A12wk=12-week-old adult. All experi-
ments were repeated with similar results on independently obtained
samples (n=3).
Table 1
Database sequence similarity of rat msl to ESTs
Accession number
of match
Library source Area of homology
(ms1/db match)
Identity (%)
(over length)
BF670302 (896 bp) Homo sapiens skeletal muscle 654^1199/2^548 84.7 (549 bp)
BF549525 (553 bp) Rattus norvegicus embryo, placenta and adult lung, brain, liver, kidney,
heart, spleen, ovary, muscle
570^1122/1^550 99.1 (553 bp)
AI172339 (388 bp) Rattus norvegicus normalised adult muscle 1284^938/4^348 99.1 (347 bp)
AW535111 (354 bp) Rattus norvegicus embryo, placenta and adult lung, brain, liver, kidney,
heart, spleen, ovary, muscle
1284^966/33^354 93.2 (323 bp)
AI060194 (301bp) Rattus norvegicus placenta, adult lung, brain, liver, kidney, heart, spleen,
ovary, muscle
1284^1010/28^301 99.3 (275 bp)
AI716006 (319 bp) Rattus norvegicus normalised eye minus lens 1251^952/9^306 94 (300 bp)
AI510175 (613 bp) Mus musculus embryo, 13.5^14.5 days post-coitum 19^630/1^613 91.4 (613 bp)
AI605651 (576 bp) Mus musculus embryo, 19.5 days post-coitum 441^1017/1^576 92.7 (577 bp)
AI414584 (404 bp) Mus musculus embryo, 19.5 days post-coitum 1221^876/62^404 91 (346 bp)
AV247903 (273 bp) Mus musculus 0-day neonate head 1170^1284/162^268 70.4 (347 bp)
AV599391 (410 bp) Bos taurus, foetal cartilage 1272^899/32^410 75.6 (381 bp)
AI721847 (618 bp) Danio rerio somite, whole embryo and adult liver 760^979/359^587 71.8 (220 bp)
AI533498 (532 bp) Drosophila melanogaster 791^1161/68^434 55.8 (380 bp)
D76164 (360 bp) Caenorhabditis elegans 1072^1033/183^322 65.7 (140 bp)
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genomic sequences from species across the phylogenetic spec-
trum (Table 1), and signi¢cant similarity of the ms1 protein
with predicted proteins from invertebrates (Fig. 3B).
4. Discussion
We report here the isolation and characterisation of a novel
gene, ms1, which is up-regulated in the very early stages of
pressure overload LVH, before any structural changes are
apparent. This suggests a possible role for ms1 in the initial
signalling of the hypertrophic response. The considerably
greater abundance of ms1 mRNA levels in heart and skeletal
muscle compared with other tissues suggests that it is highly
striated muscle-speci¢c. It is conceivable that ms1 may also
have a more fundamental role in the regulation of the ‘muscle
gene programme’ that controls di¡erentiation, growth and
sarcomeric organisation of striated muscle [16]. It should
also be noted that the normal persistence of ms1 mRNA in
the rat left ventricle beyond development and into adulthood
indicates that ms1 does not belong to the ‘foetal’ group of
genes that are re-expressed during LVH [4].
The homology of a region of the ms1 mRNA and protein
sequences to predicted genes and proteins in Drosophila me-
lanogaster and Caenorhabditis elegans (Table 1, Fig. 3B) im-
plies evolutionary conservation and thus functional impor-
tance. There is a large body of evidence demonstrating the
involvement of conserved signalling molecules in growth and
stress pathways. For instance, functionally similar sequence
homologues of the MAP kinases, p38 and JNK [17], and
the cardiac-restricted transcription factors GATA-4 and
Nkx2.5 [18] have been identi¢ed in mammals and D. mela-
nogaster. The existence of a human homologue of ms1 mRNA
is supported by 85% identity of a 3P region with a 549-base
segment of EST BF670302 (from skeletal muscle) and 83^92%
identity to di¡erent regions of a genomic clone from human
Ch8q23 (with segments of this clone almost covering the en-
tire length of ms1 mRNA).
Five rat ESTs exhibit strong identity (93^99%) with di¡er-
ent lengths of the 3P region of ms1 (Table 1). Interestingly,
sequence alignments reveal variations in length and sequence
amongst the genes represented by ESTs compared to ms1.
Although the 3P terminal 348 bases of EST AI172339 (from
a normalised muscle library) is nearly identical to ms1 (99.1%
identity), the 40 most 5P bases of this clone display very weak
homology. Three of the ESTs exhibit variation in the length
of the 3P-terminus: ESTs AI060194 and AW535111 (from
Fig. 3. A: Full-length cDNA (5P to 3P) and putative protein sequence of ms1. The 5P and 3P RACE products are indicated by shaded regions
of the nucleotide sequence, and the translation start (ATG) and stop (*) codon encoding the longest open reading frame are shown in bold.
The putative polyadenylation signals are in bold and the start (s) and end (e) of a putative IRES element is indicated by unshaded bases.
B: Alignment of ms1 putative protein sequence with a protein in Drosophila melanogaster (EG:152A3.3) and two in Caenorhabditis elegans
(F36F2.1 and T04A8.4). Shaded amino acids denote areas of identity with ms1.
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libraries derived from a mixture of tissues) possess an addi-
tional length of approximately 30 non-matching bases, be-
yond the respective 275 and 323 bases that closely match
the 3P-terminus of ms1, whereas AI716006 (from a normalised
eye library), is truncated by approximately 40 bases in com-
parison to ms1. The signi¢cance of this potential transcript
heterogeneity remains to be determined.
In the 5P UTR of certain transcripts, an IRES confers the
potential for cap-independent translation, and has been iden-
ti¢ed in various genes involved in cell growth such as c-myc
[19] and vascular endothelial growth factor [20]. The impor-
tance of the IRES is evident when there is a decline in normal
cap-dependent protein synthesis during conditions of cellular
stress, such as hypoxia [20] and apoptosis [19]. Recently,
IRES-like activity has also been demonstrated in the 3P
UTR of certain genes involved in oxidative phosphorylation
[21]. Therefore the presence of a putative IRES in the 3P UTR
of ms1 (Fig. 3A) may be relevant to its function.
In spite of intense research on the pathogenesis of LVH, the
molecular basis of this disease state remains to be fully under-
stood. Our study has identi¢ed a novel gene, ms1, that is up-
regulated signi¢cantly and in a striated muscle-speci¢c man-
ner, during the early stages of LVH development. We propose
that ms1 is a potential candidate as an early molecular trigger
in the hypertrophic cascade. Future studies will focus on the
transcription machinery that governs the regulation and tis-
sue-speci¢c expression of rat ms1 mRNA and speci¢c models
of cellular stress will be used to dissect the precise stimulus-
speci¢city of ms1 activation and function.
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